<DOC>
	<DOCNO>NCT01675219</DOCNO>
	<brief_summary>Bladder cancer ( BC ) , second common urological malignancy , important public health issue . One main challenge treatment bladder cancer prevention recurrences non-invasive tumor , also associate significant cost . The current study investigate optimal treatment patient bladder cancer high risk tumor recurrence low risk progression . The main interest comparison photodynamic ( PDD ) bladder tumor resection ( TUR-BR ) traditional TUR-BT . Also efficacy adjuvant optimize mitomycin-C compare patient adjuvant treatment .</brief_summary>
	<brief_title>Fluorescence Cystoscopy Optimized MMC Recurrent Bladder Cancer ( FinnBladder 9 )</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Primary papillary bladder cancer high risk recurrence define follow : Number primary tumor ≥2 , OR Size solitary primary tumor ≥ 3 cm , OR Recurrent papillary tumor Histologically proven Ta bladder cancer Histological grade 12 ( WHO 1973 grade system ) papillary urothelial neoplasm low malignant potential ( PUNLMP ) low grade ( WHO 2004 grade system ) bladder cancer Written inform consent require every eligible patient Grade 3 tumor ( WHO 1973 grade system ) , high grade tumor ( WHO 2004 grade system ) CIS ( carcinoma situ ) Suspicion evidence papillary tumor CIS upper urinary tract NonTCC ( transitional cell carcinoma , i.e . urothelial carcinoma ) bladder cancer Suspicion previous history patient tolerate intravesical instillation Known allergy MMC hexaminolevulinate ( HAL , Hexvix® ) Urethral stricture , stone disease , chronic urinary tract infection urological condition may compromise study participation ( judged treat physician ) Pregnancy lactate patient Other noncured malignancy ( except skin basalioma cancer situ cervix uteri malignancy remission ≥5 year ) Age &lt; 18 year Expected survival time less one year Expected poor compliance ( e.g . severe psychiatric disorder , antisocial behaviour , dementia )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>bladder cancer</keyword>
	<keyword>recurrence</keyword>
	<keyword>photodynamic diagnosis</keyword>
	<keyword>PDD</keyword>
	<keyword>cost analysis</keyword>
</DOC>